🇮🇱 QSC Peptides Israel  ·  Order from QSC →

Buy Retatrutide in Israel

EU Warehouse CAS 2381865-00-3  ·  GIP/GLP-1/Glucagon Triple Agonist  ·  5–8 days  ·  >=99% purity

Retatrutide is a triple GIP, GLP-1, and glucagon receptor agonist. Phase 2 data showed 24.2% mean body weight reduction at 48 weeks — the highest reported in any obesity pharmacotherapy trial. QSC ships to Israel from the EU regional warehouse in 5–8 business days. Israel spends approximately 5% of GDP on R&D — the world's highest ratio — with the Weizmann Institute, Technion, Hebrew University, TAU, and BGU all maintaining active research programmes in GIP/GLP-1/Glucagon Triple Agonist and related fields.

Retatrutide (CAS 2381865-00-3): Retatrutide (CAS 2381865-00-3) activates GIPR, GLP-1R and GCGR simultaneously. Triple agonism adds glucagon receptor-mediated energy expenditure to the metabolic and appetite-suppressing effects of dual incretin agonism. Fatty acid conjugation enables weekly dosing. QSC supplies research-grade Retatrutide at >=99% HPLC purity, Janoshik COA. Order at qscpeptide.com.

Buy Retatrutide — EU Warehouse to Israel

₪256 / USD 69 · 5–8 business days nationwide. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted.

Buy Retatrutide at QSC →

Israel Shipping Details

DestinationDelivery Time
Tel Aviv / Gush Dan / Rehovot5–8 business days
Jerusalem / Modi'in / Beit Shemesh6–9 business days
Haifa / Technion corridor6–9 business days
Beersheba / South District6–10 business days
North District (Galilee, Golan)6–10 business days
Tracking numberAll orders
Shipping costFree
Purity>=99% HPLC
COAJanoshik (independent)
PaymentBitcoin / USDT
PricingILS (₪) and USD listed

Mechanism of Action

Retatrutide (CAS 2381865-00-3) activates GIPR, GLP-1R and GCGR simultaneously. Triple agonism adds glucagon receptor-mediated energy expenditure to the metabolic and appetite-suppressing effects of dual incretin agonism. Fatty acid conjugation enables weekly dosing.

Retatrutide — Research Data

Phase 2 (NCT04881760): 24.2% mean weight reduction at 48 weeks. Currently in Phase 3. Israeli regulatory pathway via the Israeli Ministry of Health (MOH) Pharmaceuticals Division is expected to be streamlined given Israel's bilateral agreements with the EMA and FDA for regulatory convergence.

Available Nationwide

QSC ships Retatrutide from the EU regional warehouse to all Israeli cities: Tel Aviv and Gush Dan, Rehovot (Weizmann Institute), Jerusalem (Hebrew University, Hadassah), Haifa (Technion, Rambam), Beersheba (BGU), and all northern, southern and central districts. Israel's world-class research institutions — Weizmann, Technion, HUJI, TAU, BGU, Bar-Ilan — all within the delivery window. ILS (₪) and USD pricing shown. Payment: Bitcoin (BTC) and USDT/USDC only.

Shipping InfoAll CompoundsSemaglutideTirzepatideRetatrutideBPC-157SS-31MOTS-c

QSC Network

For Research Use Only. All compounds are exclusively for laboratory research. Not intended for human consumption. Shipped from QSC EU regional warehouse.